CXCL12 and breast carcinoma: Conversely, other researchers demonstrated that co-expression of both CXCR4 and CXCR7 resulted in decreased CXCL12-mediated intravasation of mammary carcinoma cells and fewer metastases of these tumors to the lungs (Hernandez et al., 2011; Singh et al., 2013).